Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
960 participants
OBSERVATIONAL
2017-05-01
2019-10-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case
Males with an incident diagnosis of IPF made between the 1st of February 2017 and the 5th of October 2019.
Computer-assisted telephone interview
Occupational history
Genetic analysis
To include analysis of known susceptibility markers
Controls
Males with an incident hospital outpatient attendance between the 1st of February 2017 and the 5th of October 2019 who do not have a diagnosis of IPF. At each participating centre a control clinic is randomly selected from all control clinics that the research team is able to recruit from; this clinic is the source clinic for controls for the duration of the study.
Computer-assisted telephone interview
Occupational history
Genetic analysis
To include analysis of known susceptibility markers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Computer-assisted telephone interview
Occupational history
Genetic analysis
To include analysis of known susceptibility markers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* New outpatient department attendee between February 2017 and October 2019
Exclusion Criteria
* Ever worked outside of the UK
For controls
* Unable to give informed consent
* Ever worked outside of the UK (does not include work outside the UK by members of the armed forces or merchant navy)
* Diagnosis of IPF
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wellcome Trust
OTHER
University Hospital Southampton NHS Foundation Trust
OTHER
Imperial College Healthcare NHS Trust
OTHER
Heart of England NHS Foundation Trust
UNKNOWN
Liverpool University Hospitals NHS Foundation Trust
OTHER_GOV
Papworth Hospital NHS Foundation Trust
OTHER_GOV
Nottingham University Hospitals NHS Trust
OTHER
University Hospital of South Manchester
UNKNOWN
Guy's and St Thomas' NHS Foundation Trust
OTHER
North Bristol NHS Trust
OTHER
The Leeds Teaching Hospitals NHS Trust
OTHER
Newcastle-upon-Tyne Hospitals NHS Trust
OTHER
Royal Devon and Exeter NHS Foundation Trust
OTHER
Somerset NHS Foundation Trust
OTHER
Royal Infirmary of Edinburgh
OTHER
Morriston Hospital
UNKNOWN
Aberdeen Royal Infirmary
OTHER
Worcestershire Acute Hospitals NHS Trust
OTHER
University Hospital Birmingham NHS Foundation Trust
OTHER
Portsmouth Hospitals NHS Trust
OTHER_GOV
Norfolk and Norwich University Hospitals NHS Foundation Trust
OTHER
Glasgow Royal Infirmary
OTHER
Imperial College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carl Reynolds
Role: STUDY_DIRECTOR
Imperial College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imperial Healthcare NHS Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Reynolds CJ, Sisodia R, Barber C, Moffatt M, Minelli C, De Matteis S, Cherrie JW, Newman Taylor A, Cullinan P. What role for asbestos in idiopathic pulmonary fibrosis? Findings from the IPF job exposures case-control study. Occup Environ Med. 2023 Feb;80(2):97-103. doi: 10.1136/oemed-2022-108404. Epub 2023 Jan 12.
Related Links
Access external resources that provide additional context or updates about the study.
Full study documentation
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16SM3627
Identifier Type: -
Identifier Source: org_study_id